Prospective Observational Study to Monitor and Assess the Safety of Amvuttra® [Vutrisiran] in a Real-World Cohort of hATTR Amyloidosis Patients

22/01/2024
07/05/2025
EU PAS number:
EUPAS108904
Study
Ongoing
Documents
Study protocol
Study results
Study report
Other information